NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Finbarr O Harte
University of Ulster - Coleraine / United Kingdom
Others
AD Scientific Index ID: 1585881
Ulstèr Varsitie
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Finbarr O Harte's MOST POPULAR ARTICLES
1-)
Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusionNH McClenaghan, CR Barnett, E Ah-Sing, YHA Abdel-Wahab, ...Diabetes 45 (8), 1132-1140, 19963841996
2-)
Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetesJR Lindsay, NA Duffy, AM McKillop, J Ardill, FPM O\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'Harte, PR Flatt, ...Diabetic Medicine 22 (5), 654-657, 20052462005
3-)
Chemical ablation of gastric inhibitory polypeptide receptor action by daily (Pro3) GIP administration improves glucose tolerance and ameliorates insulin resistance and …VA Gault, N Irwin, BD Green, JT McCluskey, B Greer, CJ Bailey, P Harriott, ...Diabetes 54 (8), 2436-2446, 20051872005
4-)
Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1BD Green, N Irwin, NA Duffy, VA Gault, FPM O\'harte, PR FlattEuropean journal of pharmacology 547 (1-3), 192-199, 20061752006
5-)
Effects of the novel (Pro3)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese …VA Gault, FPM O\'harte, P Harriott, MH Mooney, BD Green, PR FlattDiabetologia 46, 222-230, 20031512003
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept